Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study-Reference-Cited by-同舟云学术

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study

Published:2018-02-13 Issue:3 Volume:33 Page:405-413
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Mahlknecht Philipp¹^ORCID,Gasperi Arno²,Djamshidian Atbin¹,Kiechl Stefan¹,Stockner Heike¹,Willeit Peter¹³,Willeit Johann¹,Rungger Gregorio²,Poewe Werner¹,Seppi Klaus¹

Affiliation:

1. Department of Neurology; Innsbruck Medical University; Innsbruck Austria

2. Department of Neurology; Hospital of Bruneck; Bruneck Italy

3. Department of Public Health and Primary Care; University of Cambridge; Cambridge United Kingdom

Funder

“Pustertaler Verein zur Prävention von Herz- und Hirngefaesserkrankungen,”

Austrian Society of Neurology

Assessorat fuer Gesundheit

Gesundheitsbezirk Bruneck

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27281/fullpdf

Reference35 articles.

1. Challenges of modifying disease progression in prediagnostic Parkinson's disease;Salat;Lancet Neurol,2016

2. Toward a redefinition of Parkinson's disease;Stern;Mov Disord,2012

3. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities;Berg;Lancet Neurol,2013

4. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease;Berg;Mov Disord,2014

5. The concept of prodromal Parkinson's disease;Mahlknecht;J Parkinsons Dis,2015

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital risk score sensitively identifies presence of α-synuclein aggregation or dopaminergic deficit;2024-09-06

2. A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population;npj Parkinson's Disease;2024-06-26

3. Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?;Journal of Parkinson's Disease;2024-02-29

4. Prodromal multiple sclerosis: considerations and future utility;Journal of Neurology;2024-02-11

5. Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track?;Movement Disorders;2024-02-04